Tirzepatide and the 10-year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three-year SURMOUNT-1 trial.

Tirzepatide 對於合併肥胖與前期糖尿病成人之10年心血管疾病與第二型糖尿病預測風險的影響：三年期 SURMOUNT-1 試驗的事後分析